Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study

Metastatic pattern in colorectal cancer is strongly influenced by histological subtype

(2014) N. Hugen et al.   ANNALS OF ONCOLOGY

Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?

(2014) F.N. van Erning et al.   EUROPEAN JOURNAL OF CANCER

Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology

(2014) T.R. van Oudheusden et al.   JOURNAL OF SURGICAL ONCOLOGY

Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

(2014) Hidde J. Braam et al.   JOURNAL OF SURGICAL ONCOLOGY

Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: Are we excluding patients who may benefit?

(2014) Justin D. Rivard et al.   JOURNAL OF SURGICAL ONCOLOGY

American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer

(2014) Jesus Esquivel et al.   JOURNAL OF SURGICAL ONCOLOGY

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis from Rectal Cancer

(2013) Konstantinos I. Votanopoulos et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol

(2013) Anke M. J. Kuijpers et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades

(2013) A G Kerscher et al.   BRITISH JOURNAL OF CANCER

The Dutch Surgical Colorectal Audit

(2013) N.J. Van Leersum et al.   EJSO

Peritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy

(2013) Lawson Ung et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Safety of elective colorectal cancer surgery: Non-surgical complications and colectomies are targets for quality improvement

(2013) Daniel Henneman et al.   JOURNAL OF SURGICAL ONCOLOGY

Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies

(2013) Ingmar Königsrainer et al.   LANGENBECKS ARCHIVES OF SURGERY

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY

Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials

(2010) K. Bujko et al.   ANNALS OF ONCOLOGY

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

(2010) Olivier Glehen et al.   CANCER

Patient Selection for a Curative Approach to Carcinomatosis

(2010) Pompiliu Piso et al.   CANCER JOURNAL

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

(2010) Valery E. Lemmens et al.   INTERNATIONAL JOURNAL OF CANCER

Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?

(2009) Terence C. Chua et al.   ANNALS OF SURGERY

Quantitative intra-operative assessment of peritoneal carcinomatosis – A comparison of three prognostic tools

(2009) H.A.M. Swellengrebel et al.   EJSO